DAF-2 insulin-like signaling regulates development, longevity, and metabolism in C. elegans. This conserved signal transduction pathway consists of the DAF-2/insulin receptor; AGE-1/PI 3-kinase; PDK-1, AKT-1, and AKT-2 kinases; the DAF-18/PTEN tumor suppressor homolog; and the DAF-16/Forkhead transcription factor. Although genetic screens have identified multiple alleles of all of these genes, epistasis experiments suggest the existence of undiscovered DAF-2/insulin receptor outputs that are independent of AGE-1/PI 3-kinase. To identify components of this parallel pathway, we screened for mutations that enhance the
akt-1 null phenotype (Eak mutants). Since
akt-1 null mutants are Daf-c at 270 C but not 250 C, we mutagenized
akt-1 mutant animals and isolated F2 progeny that were now Daf-c at 250 C. We identified 30 independent mutants from a screen of approximately 21,000 haploid genomes. 26 mutants were suppressed by
daf-16 RNAi, suggesting that they are components of DAF-2 signaling. Among these, 13 had a true Eak phenotype; they form dauers at 250 C only in a homozygous
akt-1 null background. These 13 mutants define 5 complementation groups. Preliminary mapping analysis indicates that
eak-1 through
eak-5 do not correspond to known Daf or SynDaf genes. Therefore, the eak genes may define novel participants in DAF-2/insulin-like signaling. Fine mapping of these genes is ongoing.